Suchbegriffe: NEOPLASM RECURRENCE, LOCAL - , . Treffer: 84
Schutgens, EM; Picci, P; Baumhoer, D; Pollock, R; Bovée, JVMG; Hogendoorn, PCW; Dijkstra, PDS; Rueten-Budde, AJ; Jutte, PC; Traub, F; Leithner, A; Tunn, PU; Funovics, P; Sys, G; San-Julian, M; Schaap, GR; Dürr, HR; Hardes, J; Healey, J; Capanna, R; Biau, D; Gomez-Brouchet, A; Wunder, J; Cosker, TDA; Laitinen, MK; Niu, X; Kostiuk, V; van de Sande, MAJ; Adamantinoma Research Group
Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases.
J Bone Joint Surg Am. 2020; 102(19):1703-1713
Doi: 10.2106/JBJS.19.01056
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Neuwirth, M; Kalt, L; Pipam, W; Rab, M
[Long-term experience with Collagenase Clostridium Histolyticum (CCH, Xiapex®) for the treatment of Dupuytren's contracture: lessons learned].
HANDCHIR MIKROCHIR P. 2019; 51(1): 38-44.
Doi: 10.1055/a-0832-2254
Web of Science
PubMed
FullText
FullText_MUG
Margonis, GA; Buettner, S; Andreatos, N; Wagner, D; Sasaki, K; Galjart, B; Kamphues, C; Pawlik, TM; Poultsides, G; Kaczirek, K; Lønning, PE; Verhoef, C; Kreis, ME; Wolfgang, CL; Weiss, MJ
The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
J Surg Oncol. 2018; 118(7):1074-1080
Doi: 10.1002/jso.25251
Web of Science
PubMed
FullText
FullText_MUG
Eisterer, W; Piringer, G; DE Vries, A; Öfner, D; Greil, R; Tschmelitsch, J; Samonigg, H; Sölkner, L; Gnant, M; Thaler, J; Austrian Breast and Colorectal Cancer Study Group
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Anticancer Res. 2017; 37(5):2683-2691
Doi: 10.21873/anticanres.11617
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lindenmann, J; Fink-Neuboeck, N; Avian, A; Pichler, M; Habitzruther, M; Maier, A; Smolle-Juettner, FM
Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Eur J Surg Oncol. 2017; 43(2):445-453
Doi: 10.1016/j.ejso.2016.10.015
Web of Science
PubMed
FullText
FullText_MUG
Posch, F; Leitner, L; Bergovec, M; Bezan, A; Stotz, M; Gerger, A; Pichler, M; Stöger, H; Liegl-Atzwanger, B; Leithner, A; Szkandera, J
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Clin Orthop Relat Res. 2017; 475(5):1427-1435
Doi: 10.1007/s11999-017-5232-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Riedl, JM; Posch, F; Bezan, A; Szkandera, J; Smolle, MA; Winder, T; Rossmann, CH; Schaberl-Moser, R; Pichler, M; Stotz, M; Stöger, H; Gerger, A
Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance: an observational cohort study.
BMC Cancer. 2017; 17(1):415-415
Doi: 10.1186/s12885-017-3392-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Soukup, V; Čapoun, O; Cohen, D; Hernández, V; Babjuk, M; Burger, M; Compérat, E; Gontero, P; Lam, T; MacLennan, S; Mostafid, AH; Palou, J; van Rhijn, BWG; Rouprêt, M; Shariat, SF; Sylvester, R; Yuan, Y; Zigeuner, R
Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review.
Eur Urol. 2017; 72(5):801-813
Doi: 10.1016/j.eururo.2017.04.015
Web of Science
PubMed
FullText
FullText_MUG
Stacchiotti, S; Gronchi, A; Fossati, P; Akiyama, T; Alapetite, C; Baumann, M; Blay, JY; Bolle, S; Boriani, S; Bruzzi, P; Capanna, R; Caraceni, A; Casadei, R; Colia, V; Debus, J; Delaney, T; Desai, A; Dileo, P; Dijkstra, S; Doglietto, F; Flanagan, A; Froelich, S; Gardner, PA; Gelderblom, H; Gokaslan, ZL; Haas, R; Heery, C; Hindi, N; Hohenberger, P; Hornicek, F; Imai, R; Jeys, L; Jones, RL; Kasper, B; Kawai, A; Krengli, M; Leithner, A; Logowska, I; Martin Broto, J; Mazzatenta, D; Morosi, C; Nicolai, P; Norum, OJ; Patel, S; Penel, N; Picci, P; Pilotti, S; Radaelli, S; Ricchini, F; Rutkowski, P; Scheipl, S; Sen, C; Tamborini, E; Thornton, KA; Timmermann, B; Torri, V; Tunn, PU; Uhl, M; Yamada, Y; Weber, DC; Vanel, D; Varga, PP; Vleggeert-Lankamp, CLA; Casali, PG; Sommer, J
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.
Ann Oncol. 2017; 28(6):1230-1242
Doi: 10.1093/annonc/mdx054
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gschwandtner, E; Klatte, T; Swietek, N; Bures, C; Kober, F; Ott, J; Schultheis, A; Neuhold, N; Hermann, M
Increase of papillary thyroid microcarcinoma and a plea for restrictive treatment: A retrospective study of 1,391 prospective documented patients.
Surgery. 2016; 159(2): 503-511.
Doi: 10.1016/j.surg.2015.06.015
Web of Science
PubMed
FullText
FullText_MUG
Harada, Y; Izumi, H; Noguchi, H; Kuma, A; Kawatsu, Y; Kimura, T; Kitada, S; Uramoto, H; Wang, KY; Sasaguri, Y; Hijioka, H; Miyawaki, A; Oya, R; Nakayama, T; Kohno, K; Yamada, S
Strong expression of polypeptide N-acetylgalactosaminyltransferase 3 independently predicts shortened disease-free survival in patients with early stage oral squamous cell carcinoma.
Tumour Biol. 2016; 37(1):1357-1368
Doi: 10.1007/s13277-015-3928-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Stotz, M; Liegl-Atzwanger, B; Posch, F; Mrsic, E; Thalhammer, M; Stojakovic, T; Bezan, A; Pichler, M; Gerger, A; Szkandera, J
Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.
PLoS One. 2016; 11(7):e0159448-e0159448
Doi: 10.1371/journal.pone.0159448
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
von Bueren, AO; Kortmann, RD; von Hoff, K; Friedrich, C; Mynarek, M; Müller, K; Goschzik, T; Zur Mühlen, A; Gerber, N; Warmuth-Metz, M; Soerensen, N; Deinlein, F; Benesch, M; Zwiener, I; Kwiecien, R; Faldum, A; Bode, U; Fleischhack, G; Hovestadt, V; Kool, M; Jones, D; Northcott, P; Kuehl, J; Pfister, S; Pietsch, T; Rutkowski, S
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
J Clin Oncol. 2016; 34(34):4151-4160
Doi: 10.1200/JCO.2016.67.2428
Web of Science
PubMed
FullText
FullText_MUG
Wolff, I; May, M; Hoschke, B; Zigeuner, R; Cindolo, L; Hutterer, G; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Dalpiaz, O; Figenshau, RS; Madison, K; Sánchez-Chapado, M; Santiago Martin, MD; Salzano, L; Lotrecchiano, G; Shariat, SF; Hohenfellner, M; Waidelich, R; Stief, C; Miller, K; Pahernik, S; Brookman-May, S; Members of the CORONA Project and the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Group
Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database.
Eur J Surg Oncol. 2016; 42(5):744-750
Doi: 10.1016/j.ejso.2016.01.009
Web of Science
PubMed
FullText
FullText_MUG
Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691
Doi: 10.1093/annonc/mdv215
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Szkandera, J; Herzog, S; Pichler, M; Stiegelbauer, V; Stotz, M; Schaberl-Moser, R; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Renner, W; Lenz, HJ; Berghold, A; Gerger, A
LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy.
Pharmacogenomics J. 2015; 15(5):391-396
Doi: 10.1038/tpj.2015.2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Blum, A; Hofmann-Wellenhof, R; Marghoob, AA; Argenziano, G; Cabo, H; Carrera, C; Costa Soares de Sá, B; Ehrsam, E; González, R; Malvehy, J; Manganoni, AM; Puig, S; Simionescu, O; Tanaka, M; Thomas, L; Tromme, I; Zalaudek, I; Kittler, H
Recurrent melanocytic nevi and melanomas in dermoscopy: results of a multicenter study of the International Dermoscopy Society.
JAMA Dermatol. 2014; 150(2):138-145
Doi: 10.1001/jamadermatol.2013.6908
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Filipits, M; Nielsen, TO; Rudas, M; Greil, R; Stöger, H; Jakesz, R; Bago-Horvath, Z; Dietze, O; Regitnig, P; Gruber-Rossipal, C; Müller-Holzner, E; Singer, CF; Mlineritsch, B; Dubsky, P; Bauernhofer, T; Hubalek, M; Knauer, M; Trapl, H; Fesl, C; Schaper, C; Ferree, S; Liu, S; Cowens, JW; Gnant, M; Austrian Breast and Colorectal Cancer Study Group
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Clin Cancer Res. 2014; 20(5):1298-1305
Doi: 10.1158/1078-0432.CCR-13-1845
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fokas, E; Liersch, T; Fietkau, R; Hohenberger, W; Beissbarth, T; Hess, C; Becker, H; Ghadimi, M; Mrak, K; Merkel, S; Raab, HR; Sauer, R; Wittekind, C; Rödel, C
Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
J Clin Oncol. 2014; 32(15):1554-1562
Doi: 10.1200/JCO.2013.54.3769
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gerber, NU; von Hoff, K; Resch, A; Ottensmeier, H; Kwiecien, R; Faldum, A; Matuschek, C; Hornung, D; Bremer, M; Benesch, M; Pietsch, T; Warmuth-Metz, M; Kuehl, J; Rutkowski, S; Kortmann, RD
Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
Int J Radiat Oncol Biol Phys. 2014; 89(4):863-871
Doi: 10.1016/j.ijrobp.2014.04.017
Web of Science
PubMed
FullText
FullText_MUG
Mlecnik, B; Bindea, G; Angell, HK; Sasso, MS; Obenauf, AC; Fredriksen, T; Lafontaine, L; Bilocq, AM; Kirilovsky, A; Tosolini, M; Waldner, M; Berger, A; Fridman, WH; Rafii, A; Valge-Archer, V; Pagès, F; Speicher, MR; Galon, J
Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients.
Sci Transl Med. 2014; 6(228):228ra37-228ra37
Doi: 10.1126/scitranslmed.3007240
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ning, Y; Gerger, A; Zhang, W; Hanna, DL; Yang, D; Winder, T; Wakatsuki, T; Labonte, MJ; Stintzing, S; Volz, N; Sunakawa, Y; Stremitzer, S; El-Khoueiry, R; Lenz, HJ
Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy.
Mol Cancer Ther. 2014; 13(2):528-539
Doi: 10.1158/1535-7163.MCT-13-0646
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schwarzenberg, J; Czernin, J; Cloughesy, TF; Ellingson, BM; Pope, WB; Grogan, T; Elashoff, D; Geist, C; Silverman, DH; Phelps, ME; Chen, W
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Clin Cancer Res. 2014; 20(13):3550-3559
Doi: 10.1158/1078-0432.CCR-13-1440
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wackernagel, W; Holl, E; Tarmann, L; Mayer, C; Avian, A; Schneider, M; Kapp, KS; Langmann, G
Local tumour control and eye preservation after gamma-knife radiosurgery of choroidal melanomas.
Br J Ophthalmol. 2014; 98(2):218-223
Doi: 10.1136/bjophthalmol-2013-304031
Web of Science
PubMed
FullText
FullText_MUG
Belev, B; Brčić, I; Prejac, J; Golubić, ZA; Vrbanec, D; Božikov, J; Alerić, I; Boban, M; Razumović, JJ
Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
World J Gastroenterol. 2013; 19(4): 523-527.
Doi: 10.3748/wjg.v19.i4.523
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Brookman-May, S; May, M; Shariat, SF; Xylinas, E; Stief, C; Zigeuner, R; Chromecki, T; Burger, M; Wieland, WF; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Feciche, B; Truss, M; Gilfrich, C; Pahernik, S; Hohenfellner, M; Zastrow, S; Wirth, MP; Novara, G; Carini, M; Minervini, A; Simeone, C; Antonelli, A; Mirone, V; Longo, N; Simonato, A; Carmignani, G; Ficarra, V; Members of the CORONA project and the SATURN project
Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Eur Urol. 2013; 64(3):472-477
Doi: 10.1016/j.eururo.2012.06.030
Web of Science
PubMed
FullText
FullText_MUG
Fajkovic, H; Cha, EK; Jeldres, C; Robinson, BD; Rink, M; Xylinas, E; Chromecki, TF; Breinl, E; Svatek, RS; Donner, G; Tagawa, ST; Tilki, D; Bastian, PJ; Karakiewicz, PI; Volkmer, BG; Novara, G; Joual, A; Faison, T; Sonpavde, G; Daneshmand, S; Lotan, Y; Scherr, DS; Shariat, SF
Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
Eur Urol. 2013; 64(5):837-845
Doi: 10.1016/j.eururo.2012.07.026
Web of Science
PubMed
FullText
FullText_MUG
Rieken, M; Kluth, LA; Xylinas, E; Seitz, C; Fajkovic, H; Karakiewicz, PI; Lotan, Y; Briganti, A; Loidl, W; Faison, T; Crivelli, JJ; Scherr, DS; Bachmann, A; Tewari, AK; Kautzky-Willer, A; Pummer, K; Shariat, SF
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
Prostate Cancer Prostatic Dis. 2013; 16(4):367-371
Doi: 10.1038/pcan.2013.31
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Youssef, RF; Shariat, SF; Lotan, Y; Cost, N; Wood, CG; Sagalowsky, AI; Zigeuner, R; Langner, C; Chromecki, TF; Montorsi, F; Bolenz, C; Margulis, V
Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
Urol Oncol. 2013; 31(5):676-681
Doi: 10.1016/j.urolonc.2011.05.006
Web of Science
PubMed
FullText
FullText_MUG
Cha, EK; Shariat, SF; Kormaksson, M; Novara, G; Chromecki, TF; Scherr, DS; Lotan, Y; Raman, JD; Kassouf, W; Zigeuner, R; Remzi, M; Bensalah, K; Weizer, A; Kikuchi, E; Bolenz, C; Roscigno, M; Koppie, TM; Ng, CK; Fritsche, HM; Matsumoto, K; Walton, TJ; Ehdaie, B; Tritschler, S; Fajkovic, H; Martinez-Salamanca, JI; Pycha, A; Langner, C; Ficarra, V; Patard, JJ; Montorsi, F; Wood, CG; Karakiewicz, PI; Margulis, V
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Eur Urol. 2012; 61(4):818-825
Doi: 10.1016/j.eururo.2012.01.021
Web of Science
PubMed
FullText
FullText_MUG
Chromecki, TF; Cha, EK; Pummer, K; Scherr, DS; Tewari, AK; Sun, M; Fajkovic, H; Roehrborn, CG; Ashfaq, R; Karakiewicz, PI; Shariat, SF
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
BJU Int. 2012; 110(1):63-68
Doi: 10.1111/j.1464-410X.2011.10703.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Chromecki, TF; Mauermann, J; Cha, EK; Svatek, RS; Fajkovic, H; Karakiewicz, PI; Lotan, Y; Tilki, D; Bastian, PJ; Volkmer, BG; Montorsi, F; Kassouf, W; Novara, G; Fritsche, HM; Ficarra, V; Stief, CG; Dinney, CP; Skinner, E; Pummer, K; Fradet, Y; Shariat, SF
Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
World J Urol. 2012; 30(6):753-759
Doi: 10.1007/s00345-011-0772-2
Web of Science
PubMed
FullText
FullText_MUG
Fajkovic, H; Cha, EK; Jeldres, C; Donner, G; Chromecki, TF; Margulis, V; Novara, G; Lotan, Y; Raman, JD; Kassouf, W; Seitz, C; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Breinl, E; Pycha, A; Ficarra, V; Montorsi, F; Karakiewicz, PI; Scherr, DS; Shariat, SF
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
J Urol. 2012; 187(3): 845-851.
Doi: 10.1016/j.juro.2011.10.158
Web of Science
PubMed
FullText
FullText_MUG
Froehlich, EV; Scheipl, S; Lazary, A; Varga, PP; Schmid, C; Stammberger, H; Beham, A; Bodo, K; Schroettner, H; Quehenberger, F; Windhager, R; Liegl, B; Leithner, A
Expression of Ezrin, MMP-9, and COX-2 in 50 Chordoma Specimens: A Clinical and Immunohistochemical Analysis.
Spine (Phila Pa 1976). 2012; 37(13):E757-E767
Doi: 10.1097/BRS.0b013e31824782e1
Web of Science
PubMed
FullText
FullText_MUG
Lax, S; Schauer, G; Prein, K; Kapitan, M; Silbert, D; Berghold, A; Berger, A; Trauner, M
Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis.
Int J Cancer. 2012; 130(10): 2232-2239.
Doi: 10.1002/ijc.26293
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Marszalek, M; Carini, M; Chlosta, P; Jeschke, K; Kirkali, Z; Knüchel, R; Madersbacher, S; Patard, JJ; Van Poppel, H
Positive surgical margins after nephron-sparing surgery.
Eur Urol. 2012; 61(4):757-763
Doi: 10.1016/j.eururo.2011.11.028
Web of Science
PubMed
FullText
FullText_MUG
Scheipl, S; Froehlich, EV; Leithner, A; Beham, A; Quehenberger, F; Mokry, M; Stammberger, H; Varga, PP; Lazary, A; Windhager, R; Gattenloehner, S; Liegl, B
Does insulin-like growth factor 1 receptor (IGF-1R) targeting provide new treatment options for chordomas? A retrospective clinical and immunohistochemical study.
Histopathology. 2012; 60(6):999-1003
Doi: 10.1111/j.1365-2559.2012.04186.x
Web of Science
PubMed
FullText
FullText_MUG
Stupp, R; Wong, ET; Kanner, AA; Steinberg, D; Engelhard, H; Heidecke, V; Kirson, ED; Taillibert, S; Liebermann, F; Dbaly, V; Ram, Z; Villano, JL; Rainov, N; Weinberg, U; Schiff, D; Kunschner, L; Raizer, J; Honnorat, J; Sloan, A; Malkin, M; Landolfi, JC; Payer, F; Mehdorn, M; Weil, RJ; Pannullo, SC; Westphal, M; Smrcka, M; Chin, L; Kostron, H; Hofer, S; Bruce, J; Cosgrove, R; Paleologous, N; Palti, Y; Gutin, PH
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
Eur J Cancer. 2012; 48(14):2192-2202
Doi: 10.1016/j.ejca.2012.04.011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Welter, S; Grabellus, F; Bauer, S; Schuler, M; Eberhardt, W; Tötsch, M; Stamatis, G
Growth patterns of lung metastases from sarcoma: prognostic and surgical implications from histology.
Interact Cardiovasc Thorac Surg. 2012; 15(4): 612-617.
Doi: 10.1093/icvts/ivs269
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mrak, K; Jagoditsch, M; Leibl, S; Klingler, A; Tschmelitsch, J
Influence of pT3 subgroups on outcome of R0-resected colorectal tumors.
SOUTH MED J. 2011; 104(11): 722-730.
Doi: 10.1097/SMJ.0b013e3182321271
Web of Science
PubMed
FullText
FullText_MUG
Mueller, AA; Paysan, P; Schumacher, R; Zeilhofer, HF; Berg-Boerner, BI; Maurer, J; Vetter, T; Schkommodau, E; Juergens, P; Schwenzer-Zimmerer, K
Missing facial parts computed by a morphable model and transferred directly to a polyamide laser-sintered prosthesis: an innovation study.
Br J Oral Maxillofac Surg. 2011; 49(8): e67-e71.
Doi: 10.1016/j.bjoms.2011.02.007
Web of Science
PubMed
FullText
FullText_MUG
Shariat, SF; Savage, C; Chromecki, TF; Sun, M; Scherr, DS; Lee, RK; Lughezzani, G; Remzi, M; Marberger, MJ; Karakiewicz, PI; Vickers, AJ
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis.
CANCER-AM CANCER SOC. 2011; 117(13): 2892-2897.
Doi: 10.1002/cncr.25903
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Issels, RD; Lindner, LH; Verweij, J; Wust, P; Reichardt, P; Schem, BC; Abdel-Rahman, S; Daugaard, S; Salat, C; Wendtner, CM; Vujaskovic, Z; Wessalowski, R; Jauch, KW; Dürr, HR; Ploner, F; Baur-Melnyk, A; Mansmann, U; Hiddemann, W; Blay, JY; Hohenberger, P; for the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG); the European Society for Hyperthermic Oncology (ESHO)
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.
Lancet Oncol. 2010; 11(6): 561-570.
Doi: 10.1016/S1470-2045(10)70071-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zigeuner, R; Shariat, SF; Margulis, V; Karakiewicz, PI; Roscigno, M; Weizer, A; Kikuchi, E; Remzi, M; Raman, JD; Bolenz, C; Bensalah, K; Capitanio, U; Koppie, TM; Kassouf, W; Sircar, K; Patard, JJ; Fernández, MI; Wood, CG; Montorsi, F; Ströbel, P; Wheat, JC; Haitel, A; Oya, M; Guo, CC; Ng, C; Chade, DC; Sagalowsky, A; Langner, C
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
Eur Urol. 2010; 57(4):575-581
Doi: 10.1016/j.eururo.2009.11.035
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Gonzalez-Angulo, AM; Litton, JK; Broglio, KR; Meric-Bernstam, F; Rakkhit, R; Cardoso, F; Peintinger, F; Hanrahan, EO; Sahin, A; Guray, M; Larsimont, D; Feoli, F; Stranzl, H; Buchholz, TA; Valero, V; Theriault, R; Piccart-Gebhart, M; Ravdin, PM; Berry, DA; Hortobagyi, GN
High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
J Clin Oncol. 2009; 27(34):5700-5706
Doi: 10.1200/JCO.2009.23.2025
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoff, KV; Hinkes, B; Gerber, NU; Deinlein, F; Mittler, U; Urban, C; Benesch, M; Warmuth-Metz, M; Soerensen, N; Zwiener, I; Goette, H; Schlegel, PG; Pietsch, T; Kortmann, RD; Kuehl, J; Rutkowski, S
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.
Eur J Cancer. 2009; 45(7): 1209-1217.
Doi: 10.1016/j.ejca.2009.01.015
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Jost, G; Zimmerer, S; Frank, S; Cordier, D; Merlo, A
Intradural spinal metastasis of renal cell cancer. Report of a case and review of 26 published cases.
Acta Neurochir (Wien). 2009; 151(7): 815-821.
Doi: 10.1007/s00701-009-0358-6
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Margulis, V; Shariat, SF; Matin, SF; Kamat, AM; Zigeuner, R; Kikuchi, E; Lotan, Y; Weizer, A; Raman, JD; Wood, CG; Upper Tract Urothelial Carcinoma CollaborationThe Upper Tract Urothelial Carcinoma Collaboration
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration.
Cancer. 2009; 115(6): 1224-1233.
Doi: 10.1002/cncr.24135
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Gold, JS; Are, C; Kornprat, P; Jarnagin, WR; Gönen, M; Fong, Y; DeMatteo, RP; Blumgart, LH; D'Angelica, M
Increased use of parenchymal-sparing surgery for bilateral liver metastases from colorectal cancer is associated with improved mortality without change in oncologic outcome: trends in treatment over time in 440 patients.
Ann Surg. 2008; 247(1):109-117
Doi: 10.1097/SLA.0b013e3181557e47
Web of Science
PubMed
FullText
FullText_MUG
Kaddu, S; Wolf, I; Horn, M; Kerl, H
Epithelioid sarcoma with angiomatoid features: report of an unusual case arising in an elderly patient within a burn scar.
J Cutan Pathol. 2008; 35(3):324-328
Doi: 10.1111/j.1600-0560.2007.00802.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Weitere 50 Treffer anzeigen